Infectious Disease Doctors in Annandale, VA Accepting Medicare

7 Infectious Disease doctors found. Showing 1 - 7

Dr. Allan J. Morrison, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3289 Woodburn Rd, Suite # 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

Dr. Donald M. Poretz, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Suite # 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

Dr. Sujata H. Ambardar, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Suite # 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

Dr. David A. Wheeler, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Suite # 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

Dr. Ann I. Rixinger, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3289 Woodburn Rd, Suite # 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

Dr. Matthew Joseph Swierzbinski, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Suite 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

Dr. Mark Delman, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Suite 200, Annandale, VA 22003 Phone: 703-560-7900    Fax: 703-560-8408

News Archive

West Tennessee Healthcare, HealthSouth partner to jointly operate inpatient rehabilitation hospital in Jackson

West Tennessee Healthcare and HealthSouth Corporation have signed an agreement to form a joint venture to own and operate a 48-bed inpatient rehabilitation hospital in Jackson, Tennessee.

Using nanodiamonds to see smaller

Many of the most fundamental, life governing biological processes take place at size and time scales that remain invisible with current imaging technologies. Understanding how the molecules that underlie these processes move, interact and change could pave the way for new treatments, cures and the development of novel drug therapies.

CAPCC, Health Canada, Safe Kids Canada remind parents about dangers of unintentional poisoning

Kathleen Wong was frantic when her three-year-old daughter Kiana took a nibble from one of her grandfather's diabetes tablets. "We were visiting my father and he had put his medication out on the counter to take later," recalls Kathleen. "My daughter got up on a chair near the counter and took a bite of one of the pills."

Cellectis signs agreement with Harvard Apparatus for electroporation-based instruments

Cellectis, the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have announced today that they have signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, the full line of electroporation-based instruments acquired by Cellectis from CytoPulse in September of 2010.

Read more Medical News

› Verified 6 days ago